Earnings call Divi’s Laboratories reported strong Q2 FY25 results with consolidated revenue of ₹2,444 crore, up 22.5% YoY and 11.2% QoQ. Profit after tax rose 46.6% YoY to ₹510 crore. Growth was led ...
Welcome to the Divis Labs Stock Liveblog, your real-time source for the latest updates and comprehensive analysis on a ...
Divi's Laboratories Ltd (NSE:DIVISLAB) is set to release its Q2 2026 earnings on Nov 7, 2025. The consensus estimate for Q2 2026 revenue is $25.86 billion, and the earnings are expected to come in at ...
Divis Laboratories benefits from strong CDMO demand but faces high valuations, prompting a hold recommendation for investors.
Divi’s Laboratories shares gained over 3 per cent as analysts flagged 2026 as a potential inflection point, driven by a ...
Divi's Laboratories proposes ₹30 per share final dividend for FY25 Stock price reaches record ₹6,764, up 4.37 percent New long-term pharma supply deal triggers ₹650-750 crore investment Shares of ...
Stock market today: Indian equity indices remained largely unchanged on Wednesday as financial stocks retraced from their near-record peaks, counterbalancing the positive sentiment surrounding a ...
At around 9:50 a.m., shares of Divi's Laboratories fell 1.73 per cent or Rs 86.5 at Rs 4,904.75 on NSE. The market ...
Hosted on MSN
Is 2026 a turning point for Divis Laboratories? Here's what Citi says about the pharma stock
India, Jan. 15 -- The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed ...
HYDERABAD, India--(BUSINESS WIRE)--Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Divi’s Laboratories (NSE: DIVISLAB), one of the largest active ...
Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25. Q2 growth was largely led by ...
Divi’s Laboratories (DIVI) Q1FY26 EBITDA was 4% below our estimates led by lower margins despite higher CS revenues. We expect margins to improve, led by better product mix and stable raw material ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results